Archive \ Volume.8 2017 Issue 2

Unusual Case of Lamivudine-Associated Skin Rashes in an HIV/AIDS Patient: A Case Presentation

Kashif U. Khan , Amer H. Khan , Syed A. Sulaiman , Chow T. Soo , Syed I. Ahmad

In patients with human immunodeficiency virus (HIV) infection, lamivudine is used as a first-line drug for antiretroviral therapy. Lamivudine is relatively nontoxic in nature, and it can also be used during pregnancy. Herein, we describe a 43-year-old, HIV-positive female hospitalized with maculopapular, pruritic rash that appeared first on the extremities and gradually spread with systemic symptoms such as fever and myalgia after lamivudine therapy.